Lou Tianwen, Tao Borui, Chen Ming
The First Clinical Medical College, Anhui Medical University, Hefei, China; Department of Pharmacology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China.
Department of Pharmacology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China.
Neuroscience. 2023 Mar 15;514:123-140. doi: 10.1016/j.neuroscience.2023.01.032. Epub 2023 Feb 2.
Alzheimer's disease (AD) and other neurodegenerative diseases, for which there is no effective cure, cause great social burden. Apolipoprotein E (APOE) is an important lipid transporter, which has been shown to have a close relationship with AD and other neurological disorders in an increasing number of studies, suggesting its potential as a therapeutic target. In this review, we summarize the recent advances in clinical and basic research on the role of APOE in the pathogenesis of multiple neurological diseases, with an emphasis on the new associations between APOE and AD, and between APOE and depression. The progress of APOE research in Parkinson's disease (PD) and some other neurological diseases is briefly discussed.
阿尔茨海默病(AD)和其他神经退行性疾病目前尚无有效治愈方法,给社会带来了沉重负担。载脂蛋白E(APOE)是一种重要的脂质转运蛋白,越来越多的研究表明它与AD及其他神经系统疾病密切相关,提示其作为治疗靶点的潜力。在本综述中,我们总结了APOE在多种神经疾病发病机制中作用的临床和基础研究的最新进展,重点关注APOE与AD以及APOE与抑郁症之间的新关联。还简要讨论了APOE在帕金森病(PD)和其他一些神经疾病中的研究进展。